Versant Ventures VI GP-GP, LLC's Net Worth
Estimate Recalculated Nov 11, 2024 01:47PM EST
Who is Versant Ventures VI GP-GP, LLC
Versant Ventures VI GP-GP, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Pandion Therapeutics Holdco LLC, Passage BIO, Inc., Contineum Therapeutics, Inc., LENZ Therapeutics, Inc., Repare Therapeutics Inc., Century Therapeutics, Inc., Tempest Therapeutics, Inc., and Akero Therapeutics, Inc..
SEC CIK
Versant Ventures VI GP-GP, LLC's CIK is 0001777652
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
